The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases were used to compare the expression of SIGLEC9. Then, we measured the expression of SIGLEC9 with immunohistochemical staining on 177 patients with gliomas to validate the results. The gene discussed is SIGLEC9; the disease is glioma.